Gastrointestinal Stromal Tumour (GIST) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
Condition: Gastrointestinal Stromal TumourInterventions: Drug: Regorafenib; Drug: imatinibSponsor: Australasian Gastro-Intestinal Trials GroupRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2014 Category: Research Source Type: clinical trials
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
Condition: Gastrointestinal Stromal TumourInterventions: Drug: Regorafenib; Drug: imatinibSponsor: Australasian Gastro-Intestinal Trials GroupRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2014 Category: Research Source Type: clinical trials
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
Condition: Gastrointestinal Stromal TumourInterventions: Drug: Regorafenib; Drug: imatinibSponsor: Australasian Gastro-Intestinal Trials GroupRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2014 Category: Research Source Type: clinical trials
